4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
uniQure N.V. (QURE) operates in the Biotechnology industry and is headquartered in Amsterdam, Netherlands with about 221 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, QURE reported $16M in revenue and ($199M) in net income.
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding.
Interactive charts & full statements → Open the QURE valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $16M | $27M | $16M | $106M |
| Gross Profit | $14M | $9M | $2M | $103M |
| Operating Income (EBIT) | ($188M) | ($182M) | ($282M) | ($144M) |
| Net Income | ($199M) | ($240M) | ($308M) | ($127M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $4M | $6M | $4M | $5M | $2M |
| Gross Profit | $3M | $5M | $3M | $5M | $1M |
| Operating Income (EBIT) | ($44M) | ($52M) | ($50M) | ($43M) | ($37M) |
| Net Income | ($54M) | ($37M) | ($80M) | ($38M) | ($44M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $825M | $556M | $832M | $705M | — |
| Total Liabilities | $626M | $563M | $624M | $229M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive QURE viewer.
About TickerBase · Data methodology & sources